NEPH - Nephros - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

NEPH is currently covered by 1 analysts with an average price target of $6. This is a potential upside of $3.39 (129.89%) from yesterday's end of day stock price of $2.61.

Nephros's activity chart (see below) currently has 11 price targets and 11 ratings on display. The stock rating distribution of NEPH is 100% BUY.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 41.07% of the time, taking 747.5 days on average.

Highest price target for NEPH is $6, Lowest price target is $6, average price target is $6.

Most recent stock forecast was given by ROBERT WASSERMAN from STONEX on 18-Mar-2026. First documented stock forecast 24-Oct-2019.

Best performing analysts who are covering NEPH - Nephros:

Robert Wasserman Marc Wiesenberger

Currently out of the existing stock ratings of NEPH, 1 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 24-Oct-2019

$6

$3.39 (129.89%)

$5

8 months 4 days ago
(18-Mar-2026)

4/7 (57.14%)

$2.94 (96.08%)

245

Buy Since 26-Jan-2021

$5.25

$8

4 years 6 months 17 days ago
(05-May-2022)

1/4 (25%)

$2.72 (107.51%)

1250

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NEPH (Nephros) average time for price targets to be met?

On average it took 748 days for the stock forecasts to be reached, with an average price target met ratio of 41.07%.

Which analyst most recently updated their price target on NEPH (Nephros)?

Robert Wasserman

Which analyst has the lowest performance score on NEPH (Nephros) with a proven track record?

MARC WIESENBERGER

Which analyst has the most public recommendations on NEPH (Nephros)?

Robert Wasserman has 2 price targets and 1 ratings on NEPH

Which analyst is the currently most bullish on NEPH (Nephros)?

Robert Wasserman with the highest potential upside of $3.39

Which analyst is the currently most reserved on NEPH (Nephros)?

Marc Wiesenberger with the lowest potential downside of $2.64
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?